この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2022/8/111 分で読めます
Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Multivalent Vaccines for Rabies Virus and Coronaviruses
ローカル自動翻訳 · 情報源の原言語
概要
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Thomas Jefferson University, located in Philadelphia, Pennsylvania to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →